Pardes Biosciences Number Of Employees vs. Shares Owned By Insiders

PRDSDelisted Stock  USD 2.14  0.01  0.47%   
Based on Pardes Biosciences' profitability indicators, Pardes Biosciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Pardes Biosciences' ability to earn profits and add value for shareholders.
For Pardes Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pardes Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pardes Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pardes Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pardes Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note, there is a significant difference between Pardes Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pardes Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pardes Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pardes Biosciences Shares Owned By Insiders vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Pardes Biosciences's current stock value. Our valuation model uses many indicators to compare Pardes Biosciences value to that of its competitors to determine the firm's financial worth.
Pardes Biosciences is rated below average in number of employees category among its peers. It is rated below average in shares owned by insiders category among its peers making about  0.24  of Shares Owned By Insiders per Number Of Employees. The ratio of Number Of Employees to Shares Owned By Insiders for Pardes Biosciences is roughly  4.23 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Pardes Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pardes Number Of Employees vs. Competition

Pardes Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,339. Pardes Biosciences holds roughly 57.0 in number of employees claiming about 4% of equities under Health Care industry.

Pardes Shares Owned By Insiders vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Pardes Biosciences

Number of Employees

 = 

Full Time

+

Part Time

 = 
57
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Pardes Biosciences

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
13.47 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Pardes Shares Owned By Insiders Comparison

Pardes Biosciences is currently under evaluation in shares owned by insiders category among its peers.

Pardes Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Pardes Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pardes Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Pardes Biosciences' change in net profit over the period of time. It can combine multiple indicators of Pardes Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. The company was incorporated in 2020 and is headquartered in Carlsbad, California. Pardes Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.

Pardes Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Pardes Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pardes Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pardes Biosciences' important profitability drivers and their relationship over time.

Use Pardes Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pardes Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will appreciate offsetting losses from the drop in the long position's value.

Pardes Biosciences Pair Trading

Pardes Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Pardes Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pardes Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pardes Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pardes Biosciences to buy it.
The correlation of Pardes Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pardes Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pardes Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pardes Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Pardes Biosciences position

In addition to having Pardes Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Semiconductor Thematic Idea Now

Semiconductor
Semiconductor Theme
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Pardes Stock

If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets